Accustem has appointed a senior R&D and regulatory advisor to lead assay development, clinical validation, and regulatory strategy across its growing pipeline.
The hire brings experience taking genomic tests from early research through to regulatory approval, including FDA clearance and IVDR compliance. This expertise will support the development of robust clinical evidence and ensure products are positioned for successful market entry and adoption.
The appointment comes at a key stage for Accustem as it continues to build out its pipeline and move closer to commercialisation. Strengthening capability across development and regulation will be critical to maintaining pace while meeting the demands of clinical and regulatory standards.
Wenham Carter supported the process, identifying a leader with the technical depth and regulatory track record needed to bridge early-stage science and real-world application, helping turn promising innovation into clinically viable products.
